News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
557,792 Results
Type
Article (34640)
Company Profile (129)
Press Release (523023)
Section
Business (163407)
Career Advice (1370)
Deals (29441)
Drug Delivery (86)
Drug Development (63471)
Employer Resources (97)
FDA (14635)
Job Trends (12549)
News (278291)
Policy (27603)
Tag
Academia (2231)
Alliances (41286)
Alzheimer's disease (1075)
Approvals (14610)
Artificial intelligence (144)
Bankruptcy (272)
Best Places to Work (10199)
Breast cancer (174)
Cancer (1306)
Cardiovascular disease (111)
Career advice (1183)
Cell therapy (261)
Clinical research (51778)
Collaboration (461)
Compensation (209)
COVID-19 (2022)
C-suite (119)
Data (1319)
Diabetes (162)
Diagnostics (5512)
Drug pricing (88)
Earnings (61768)
Events (77020)
Executive appointments (428)
FDA (15348)
Funding (412)
Gene therapy (168)
GLP-1 (500)
Government (4024)
Healthcare (17190)
Infectious disease (2103)
Inflammatory bowel disease (100)
Interviews (187)
IPO (13403)
Job creations (2721)
Job search strategy (1034)
Layoffs (243)
Legal (5939)
Lung cancer (194)
Manufacturing (194)
Medical device (13635)
Medtech (13639)
Mergers & acquisitions (16318)
Metabolic disorders (407)
Neuroscience (1366)
NextGen: Class of 2025 (5752)
Non-profit (3978)
Northern California (1510)
Obesity (228)
Opinion (139)
Parkinson's disease (89)
Patents (107)
People (49528)
Phase I (15773)
Phase II (22689)
Phase III (17567)
Pipeline (537)
Postmarket research (1988)
Preclinical (5932)
Radiopharmaceuticals (218)
Rare diseases (222)
Real estate (4959)
Regulatory (19034)
Research institute (2091)
Resumes & cover letters (187)
Southern California (1275)
Startups (2835)
United States (13763)
Vaccines (403)
Weight loss (160)
Date
Today (131)
Last 7 days (762)
Last 30 days (1820)
Last 365 days (29952)
2025 (1112)
2024 (30140)
2023 (34607)
2022 (44674)
2021 (48270)
2020 (47679)
2019 (41920)
2018 (31724)
2017 (27696)
2016 (26534)
2015 (30542)
2014 (23019)
2013 (19210)
2012 (20890)
2011 (21566)
2010 (19803)
Location
Africa (587)
Arizona (146)
Asia (34780)
Australia (6658)
California (3346)
Canada (1391)
China (318)
Colorado (169)
Connecticut (189)
Europe (72327)
Florida (539)
Georgia (120)
Illinois (387)
Indiana (201)
Japan (88)
Maryland (612)
Massachusetts (2506)
Michigan (123)
Minnesota (255)
New Jersey (1044)
New York (993)
North Carolina (727)
Northern California (1510)
Ohio (139)
Pennsylvania (877)
South America (892)
Southern California (1275)
Texas (521)
Utah (102)
Washington State (373)
557,792 Results for "concord medical services holdings limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Concord Medical Files 2023 Annual Report on Form 20-F
Concord Medical Services Holdings Limited today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the “Annual Report”) with the U.S. Securities and Exchange Commission.
April 19, 2024
·
1 min read
Policy
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
Concord Medical Services Holdings Limited announced that it has received a letter from the New York Stock Exchange dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company’s American depositary shares and that the applicable cure period for the Company to regain compliance expires on August 12, 2024.
February 20, 2024
·
3 min read
Press Releases
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
December 9, 2024
·
3 min read
Press Releases
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment
September 16, 2024
·
3 min read
Business
Concord Medical Reports Financial Results for the First Half of 2023
Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023.
September 22, 2023
·
15 min read
Press Releases
Concord Medical Regains Compliance with NYSE Minimum Price Requirement
August 7, 2024
·
2 min read
Business
CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE
July 15, 2024
·
3 min read
Press Releases
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
January 8, 2025
·
4 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
January 14, 2025
·
5 min read
Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson
Concord Medical Services Holdings Limited announced the successful holding of the Second Annual Academic Meeting jointly by Shanghai Concord Cancer Center and The University of Texas MD Anderson Cancer Center on November 11 and November 12, 2022.
November 16, 2022
·
4 min read
1 of 55,780
Next
